Showing results (1-10 of 98) with videos related to
Sort By:
Pageof 10
Cellular Immunology|November 1, 1988
Modulation of interferon-gamma-induced major histocompatibility (MHC) and CD14 antigen changes by lipophilic muramyltripeptide MTP-PE in human monocytesR Landmann, M Wesp, P DukorProceedings of the National Academy of Sciences of the United States of America|October 1, 1970
Tissue localization of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexesP Dukor, C Bianco, V NussenzweigInfection and Immunity|April 1, 1978
Modulations of myelopoiesis in vivo by chemically pure preparations of cell wall components from gram-negative bacteria: effects at different stagesF G Staber, L Tarcsay, P DukorJournal of Immunology (Baltimore, Md. : 1950)|May 1, 1976
Trypsin increases in vitro antibody synthesis and substitutes for helper T cellsR H Gisler, T L Vischer, P DukorEuropean Journal of Immunology|December 1, 1994
IgG isotype distribution of local and systemic immune responses induced by influenza virus infectionG Fazekas, B Rosenwirth, P Dukor, et al.International Journal of Immunopharmacology|February 1, 1996
Oral administration of muramyl dipeptide into mice modulates cell proliferation, immunoglobulin synthesis and cytokine mRNA levels in gut associated lymphoid tissuesM Zunić, F Kricek, P Dukor, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1985
Induction of tumouricidal leucocytes by the intranasal application of MTP-PE, a lipophilic muramyl peptideA F Brownbill, D G Braun, P Dukor, et al.Scandinavian Journal of Immunology|September 1, 1996
Kinetics and isotype profile of rheumatoid factor production during viral infection: organ distribution of antibody secreting cellsG Fazekas, B Rosenwirth, P Dukor, et al.Immunopharmacology|September 1, 1993
Control of IgE responses. II. Isotype specific suppression of peak hapten specific IgE antibody forming cell responses in BPO-KLH sensitized mice after oral administration of muramyldipeptide or murabutideD L Auci, S M Chice, P Dukor, et al.International Journal of Immunopharmacology|February 1, 1995
Immunopharmacological activities and clinical development of muramyl peptides with particular emphasis on murabutideG M Bahr, E Darcissac, D Bevec, et al.Pageof 10